BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• 

  Genetown

  Bristol-Myers Squibb and Harvard Stem Cell Institute Team Up

  Bristol-Myers Squibb and the Harvard Fibrosis Network, part of the Harvard Stem Cell Institute, have launched a collaboration to discover and develop new therapies for fibrotic diseases.

  April 12, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  GSK Divests Rare Disease Gene Therapy Business to Orchard Therapeutics

  GlaxoSmithKline Chief Executive Officer Emma Walmsley continues to trim excess fat from the company. This morning the company announced it has divested its rare disease gene therapy portfolio to Orchard Therapeutics.

  April 12, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Most Important Things To Do if You Get Fired From Your Job

  It’s likely your worst-case professional scenario – being fired from your job. But being fired doesn’t always have to spell failure for your professional life or your morale level.

  April 12, 2018

   · 

  5 min read
• 

  Business

  Boehringer Ingelheim Strikes a Series of Investments and Collaborations Worldwide

  The last week has marked plenty of investment activity in operations, collaborations and PR the last week or two for Ingelheim, Germany-based Boehringer Ingelheim.

  April 12, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Another Notch on the Belt as Ramaswamy Launches Genevant

  Biotech investor Vivek Ramaswamy has launched another company. This time his company, dubbed Genevant, will focus on the development of RNA-based therapies and is the combined product of Roivant Sciences and Arbutus Biopharma Corporation.

  April 12, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Launches Criminal Investigation into Rational Vaccines Over Unauthorized Herpes Research

  One month after three patients who developed adverse reactions following injections of an unauthorized herpes vaccine filed a lawsuit against Rational Vaccines, the U.S. Food and Drug Administration has launched a criminal investigation into the matter.

  April 12, 2018

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Eloxx Pharmaceuticals: Promising Treatment for Rare Genetic Diseases

  The people at Eloxx Pharmaceuticals share a common goal — to bring safe and effective therapies to children and adults suffering from rare genetic diseases as quickly as possible.

  April 12, 2018

   · 

  5 min read

   · 

  Don McCormick
• 

  Business

  New Biotech Incubator Will Have New Business Model

  Alexandria Real Estate Equities, an urban office real estate investment company specializing in the life sciences, is expanding its Alexandria LaunchLabs into the East Cambridge, Massachusetts area.

  April 12, 2018

   · 

  2 min read

   · 

  Mark Terry
• Business

  Dr. Rudolph Tanzi Keynote Speaker at “Brain Awakening” Conference

  World-renowned Alzheimer’s disease and brain aging researcher Dr. Rudolph Tanzi will be a keynote speaker at the 26th American Academy of Anti-Aging Medicine (A4M) Conference (https://www.a4m.com/spring-congress-2018/home.html) in Hollywood, Florida on Saturday, April 14.

  April 12, 2018

   · 

  3 min read
• Drug Development

  Adynxx Announces Results of the ADYX-004 Phase 2 Study of Brivoligide (AYX1) for the Treatment of Post-Surgical Pain

  Brivoligide reduced post-surgical pain, opioid use and time to achieve mild pain in an underserved patient population that suffers from inadequate pain relief following surgery

  April 12, 2018

   · 

  6 min read